{"transactions":[{"id":725861,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2026-06-26T20:14:27.000Z","date":"2026-06-25","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 25, 2026, the reporting person was granted 10,000 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, which will vest in accordance with the following schedule: 10,000 shares on June 25, 2027."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":221146,"source":{"system":"sec-edgar","filing":"0001104659-26-078266","document":"tm2619089-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465926078266/tm2619089-1_4seq1.xml","form_type":"4"}},{"id":832764,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT, CEO & CHAIRMAN"}}],"security":"Common stock, par value $0.001","published_at":"2026-03-20T20:05:13.000Z","date":"2026-03-18","kind":"grant","planned":false,"acquired":true,"shares":475424,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted 475,424 restricted shares pursuant to the Issuer's Long-Term Incentive Plan on March 18, 2026."}],"balance_after":4586841,"source":{"system":"sec-edgar","filing":"0000941841-26-000002","document":"form4-03202026_040304.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000094184126000002/form4-03202026_040304.xml","form_type":"4"}},{"id":1072637,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2025-08-07T21:18:06.000Z","date":"2025-08-05","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On August 5, 2025, the reporting person was granted 50,000 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, which will vest in accordance with the following schedule: 16,667 shares on August 5, 2028, 16,667 shares on August 5, 2029 and 16,666 shares on August 5, 2030."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":211146,"source":{"system":"sec-edgar","filing":"0001104659-25-075272","document":"tm2522819-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465925075272/tm2522819-5_4seq1.xml","form_type":"4"}},{"id":1091529,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2025-07-08T01:50:05.000Z","date":"2025-06-25","kind":"grant","planned":false,"acquired":true,"shares":7173,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On June 25, 2025, the reporting person was granted 7,173 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, which will vest in full on June 25, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":161146,"source":{"system":"sec-edgar","filing":"0001104659-25-066239","document":"tm2520050-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465925066239/tm2520050-4_4seq1.xml","form_type":"4"}},{"id":1129786,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2025-05-30T15:19:22.000Z","date":"2025-05-30","kind":"other","planned":false,"acquired":false,"shares":207007,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Disposed of in connection with an offer made pursuant to the Agreement and Plan of Merger, dated as of March 9, 2025 and as amended on April 14, 2025 (the \"Merger Agreement\"), in exchange for $4.10 per share, net to the holder in cash, plus one contractual contingent value right (\"CVR\") per share. Each CVR represents the right to receive a payment ranging from $0.20 to $0.70 pursuant to certain milestone payments as defined in the Merger Agreement relating to the regulatory approval for cosibelimab in the European Union. The CVR milestone must be achieved within thirty-six (36) months after the date on which a marketing authorization application or equivalent application for cosibelimab receives a positive validation outcome by the European Medicines Agency."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-25-054692","document":"tm2516581-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465925054692/tm2516581-6_4seq1.xml","form_type":"4"}},{"id":1129785,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2025-05-30T15:19:22.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":1.29,"value":64500.0,"ownership":{"direct":true},"balance_after":207007,"source":{"system":"sec-edgar","filing":"0001104659-25-054692","document":"tm2516581-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465925054692/tm2516581-6_4seq1.xml","form_type":"4"}},{"id":1129784,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2025-05-30T15:19:22.000Z","date":"2025-05-28","kind":"grant","planned":false,"acquired":true,"shares":12195,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes restricted shares of Common Stock which vest over various time periods, subject to Mr. Rosenwald's continued service on the board."}],"balance_after":157007,"source":{"system":"sec-edgar","filing":"0001104659-25-054692","document":"tm2516581-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465925054692/tm2516581-6_4seq1.xml","form_type":"4"}},{"id":1316643,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT, CEO & CHAIRMAN"}}],"security":"Common stock, par value $0.001","published_at":"2025-01-03T21:15:06.000Z","date":"2025-01-01","kind":"grant","planned":false,"acquired":true,"shares":454153,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted 454,153 restricted shares pursuant to the Issuer's Long-Term Incentive Plan on January 1, 2025."}],"balance_after":4111417,"source":{"system":"sec-edgar","filing":"0001415889-25-000400","document":"form4-01032025_040103.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000141588925000400/form4-01032025_040103.xml","form_type":"4"}},{"id":1329746,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2024-12-18T02:32:39.000Z","date":"2024-12-13","kind":"grant","planned":false,"acquired":true,"shares":12638,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents previously-granted performance-based award that became vested upon achievement of a corporate milestone on December 13, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of restricted common stock, which vest over various time periods."}],"balance_after":144812,"source":{"system":"sec-edgar","filing":"0001104659-24-129526","document":"tm2431396-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465924129526/tm2431396-6_4seq1.xml","form_type":"4"}},{"id":1399727,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee stock option (right to buy)","published_at":"2024-09-25T20:59:33.000Z","date":"2024-09-23","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in accordance with the following schedule: (i) one-third of the shares subject to the option vest on January 1, 2025; (ii) one-third of the shares subject to the option vest on January 1, 2026; and (iii) one-third of the shares subject to the option vest on January 1, 2027."}],"balance_after":30000,"derivative":{"exercise_price":2.46,"expiration_date":"2034-09-23","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-24-102840","document":"tm2424771-7_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465924102840/tm2424771-7_4seq1.xml","form_type":"4"}},{"id":1399726,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT, CEO & CHAIRMAN"}}],"security":"Warrants to Purchase Common Stock","published_at":"2024-09-25T20:45:04.000Z","date":"2024-09-23","kind":"purchase","planned":false,"acquired":true,"shares":763359,"price":0.125,"value":95419.875,"ownership":{"direct":true},"balance_after":763359,"derivative":{"exercise_price":1.84,"exercise_date":"2025-03-23","expiration_date":"2030-03-23","underlying":"Common Stock","underlying_shares":763359},"source":{"system":"sec-edgar","filing":"0001415889-24-023957","document":"form4-09252024_040901.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/941841/000141588924023957/form4-09252024_040901.xml","form_type":"4"}},{"id":1399725,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT, CEO & CHAIRMAN"}}],"security":"Common stock, par value $0.001","published_at":"2024-09-25T20:45:04.000Z","date":"2024-09-23","kind":"purchase","planned":false,"acquired":true,"shares":763359,"price":1.84,"value":1404580.56,"ownership":{"direct":true},"balance_after":3657264,"source":{"system":"sec-edgar","filing":"0001415889-24-023957","document":"form4-09252024_040901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000141588924023957/form4-09252024_040901.xml","form_type":"4"}},{"id":1454870,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President, CEO & Chairman"}}],"security":"SERIES A CUMULATIVE PERPETUAL PREFERRED STOCK","published_at":"2024-07-15T20:05:14.000Z","date":"2024-07-11","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":7.4835,"value":37417.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on July 11, 2024 was $7.35 to $7.49. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a stockholder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":127500,"source":{"system":"sec-edgar","filing":"0001104659-24-079855","document":"tm2419471-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465924079855/tm2419471-1_4seq1.xml","form_type":"4"}},{"id":1456482,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President, CEO & Chairman"}}],"security":"SERIES A CUMULATIVE PERPETUAL PREFERRED STOCK","published_at":"2024-07-11T12:00:09.000Z","date":"2024-07-09","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":7.3942,"value":36971.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on July 9, 2024 was $7.25 to $7.48. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a stockholder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":122500,"source":{"system":"sec-edgar","filing":"0001104659-24-079100","document":"tm2419219-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465924079100/tm2419219-1_4seq1.xml","form_type":"4"}},{"id":1457110,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2024-07-10T20:43:34.000Z","date":"2024-07-08","kind":"grant","planned":false,"acquired":true,"shares":9728,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On July 8, 2024, the reporting person was granted 9,728 restricted stock units pursuant to the Issuer's 2015 Stock Plan, which will vest in full on July 8, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":153973,"source":{"system":"sec-edgar","filing":"0001104659-24-078968","document":"tm2419199-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465924078968/tm2419199-1_4seq1.xml","form_type":"4"}},{"id":1457109,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President, CEO & Chairman"}}],"security":"SERIES A CUMULATIVE PERPETUAL PREFERRED STOCK","published_at":"2024-07-10T12:30:11.000Z","date":"2024-07-08","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":7.3529,"value":36764.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on July 8, 2024 was $7.29 to $7.47. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a stockholder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":117500,"source":{"system":"sec-edgar","filing":"0001104659-24-078786","document":"tm2419164-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465924078786/tm2419164-1_4seq1.xml","form_type":"4"}},{"id":1466494,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President, CEO & Chairman"}}],"security":"COMMON STOCK, PAR VALUE $0.001","published_at":"2024-07-01T12:40:16.000Z","date":"2024-06-28","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":1.6362,"value":32724.0,"ownership":{"direct":true},"balance_after":2893905,"source":{"system":"sec-edgar","filing":"0001104659-24-076591","document":"tm2418613-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465924076591/tm2418613-1_4seq1.xml","form_type":"4"}},{"id":1509607,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President, CEO & Chairman"}}],"security":"COMMON STOCK, PAR VALUE $0.001","published_at":"2024-05-20T21:00:38.000Z","date":"2024-05-16","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":1.7589,"value":17589.0,"ownership":{"direct":true},"balance_after":2873905,"source":{"system":"sec-edgar","filing":"0001104659-24-063455","document":"tm2415000-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465924063455/tm2415000-2_4seq1.xml","form_type":"4"}},{"id":1514938,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2024-05-16T23:32:50.000Z","date":"2024-05-14","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The 50,000 shares of restricted Common Stock will vest according to the following schedule, subject to Mr. Rosenwald's continued service on the board on each date: one third on May 14, 2027, one third on May 14, 2028, and one third on May 14, 2029."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted shares of Common Stock which vest over various time periods, subject to Mr. Rosenwald's continued service on the board."}],"balance_after":132174,"source":{"system":"sec-edgar","filing":"0001104659-24-062664","document":"tm2414703-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465924062664/tm2414703-3_4seq1.xml","form_type":"4"}},{"id":1514937,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2024-05-16T23:32:50.000Z","date":"2024-05-14","kind":"grant","planned":false,"acquired":true,"shares":32051,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 32,051 shares of restricted Common Stock will vest on May 14, 2027, subject to Mr. Rosenwald's continued service on the board on such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted shares of Common Stock which vest over various time periods, subject to Mr. Rosenwald's continued service on the board."}],"balance_after":82174,"source":{"system":"sec-edgar","filing":"0001104659-24-062664","document":"tm2414703-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465924062664/tm2414703-3_4seq1.xml","form_type":"4"}},{"id":1559908,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2024-03-27T11:00:16.000Z","date":"2024-03-25","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":3.04,"value":30400.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":144245,"source":{"system":"sec-edgar","filing":"0001104659-24-039354","document":"tm249895-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465924039354/tm249895-1_4seq1.xml","form_type":"4"}},{"id":1562430,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2024-03-25T20:01:23.000Z","date":"2024-03-22","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":3.4,"value":68000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":134245,"source":{"system":"sec-edgar","filing":"0001104659-24-038431","document":"tm249705-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465924038431/tm249705-1_4seq1.xml","form_type":"4"}},{"id":1683214,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President, CEO & Chairman"}}],"security":"COMMON STOCK, PAR VALUE $0.001","published_at":"2024-01-09T13:15:16.000Z","date":"2024-01-05","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":2.3754,"value":118770.0,"ownership":{"direct":true},"balance_after":2863905,"source":{"system":"sec-edgar","filing":"0001104659-24-002464","document":"tm242385-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465924002464/tm242385-1_4seq1.xml","form_type":"4"}},{"id":1694427,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President, CEO & Chairman"}}],"security":"COMMON STOCK, PAR VALUE $0.001","published_at":"2024-01-03T21:46:48.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":216465,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted 216,465 restricted shares pursuant to the Issuer's Long-Term Incentive Plan on January 1, 2024."}],"balance_after":2813905,"source":{"system":"sec-edgar","filing":"0001104659-24-000898","document":"tm241755-10_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465924000898/tm241755-10_4seq1.xml","form_type":"4"}},{"id":1739746,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President, CEO & Chairman"}}],"security":"Warrants to purchase Common Stock","published_at":"2023-11-16T22:50:28.000Z","date":"2023-11-14","kind":"purchase","planned":false,"acquired":true,"shares":1567515,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares of common stock and warrants to purchase common stock reflect on this Form 4 were purchased as units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock, at a price per unit of $1.70."}],"balance_after":1567515,"derivative":{"exercise_price":1.7,"exercise_date":"2023-11-14","expiration_date":"2028-11-14","underlying":"Common Stock","underlying_shares":1567515},"source":{"system":"sec-edgar","filing":"0001104659-23-119188","document":"tm2330934-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465923119188/tm2330934-2_4seq1.xml","form_type":"4"}},{"id":1739745,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President, CEO & Chairman"}}],"security":"COMMON STOCK, PAR VALUE $0.001","published_at":"2023-11-16T22:50:28.000Z","date":"2023-11-14","kind":"purchase","planned":false,"acquired":true,"shares":1567515,"price":1.7,"value":2664775.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Effective October 10, 2023, the Issuer effected a one-for-fifteen reverse stock split of its common stock (the \"Reverse Split\"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Split."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The shares of common stock and warrants to purchase common stock reflect on this Form 4 were purchased as units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock, at a price per unit of $1.70."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Effective October 10, 2023, the Issuer effected a one-for-fifteen reverse stock split of its common stock (the \"Reverse Split\"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Split."}],"balance_after":2597440,"source":{"system":"sec-edgar","filing":"0001104659-23-119188","document":"tm2330934-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465923119188/tm2330934-2_4seq1.xml","form_type":"4"}},{"id":1772845,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President, CEO & Chairman"}}],"security":"COMMON STOCK, PAR VALUE $0.001","published_at":"2023-09-27T12:20:13.000Z","date":"2023-09-26","kind":"purchase","planned":false,"acquired":true,"shares":100000,"price":0.2833,"value":28330.0,"ownership":{"direct":true},"balance_after":15449091,"source":{"system":"sec-edgar","filing":"0001104659-23-104099","document":"tm2327003-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465923104099/tm2327003-1_4.xml","form_type":"4"}},{"id":1783415,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-09-12T13:03:33.000Z","date":"2023-09-08","kind":"purchase","planned":false,"acquired":true,"shares":348675,"price":0.72,"value":251046.0,"ownership":{"direct":true},"balance_after":354318,"source":{"system":"sec-edgar","filing":"0001437749-23-025643","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000143774923025643/rdgdoc.xml","form_type":"4"}},{"id":1785128,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2023-09-08T17:25:10.000Z","date":"2023-09-06","kind":"purchase","planned":false,"acquired":true,"shares":100000,"price":2.23,"value":223000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes restricted stock units, which vest over various time periods."}],"balance_after":114245,"source":{"system":"sec-edgar","filing":"0001104659-23-099229","document":"tm2325760-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465923099229/tm2325760-1_4seq1.xml","form_type":"4"}},{"id":1801118,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President, CEO & Chairman"}}],"security":"SERIES A CUMULATIVE PERPETUAL PREFERRED STOCK","published_at":"2023-08-21T12:30:35.000Z","date":"2023-08-18","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":9.34,"value":93400.0,"ownership":{"direct":true},"balance_after":112500,"source":{"system":"sec-edgar","filing":"0001104659-23-093700","document":"tm2324200-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465923093700/tm2324200-1_4seq1.xml","form_type":"4"}},{"id":1801117,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President, CEO & Chairman"}}],"security":"SERIES A CUMULATIVE PERPETUAL PREFERRED STOCK","published_at":"2023-08-21T12:30:35.000Z","date":"2023-08-17","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":11.75,"value":117500.0,"ownership":{"direct":true},"balance_after":102500,"source":{"system":"sec-edgar","filing":"0001104659-23-093700","document":"tm2324200-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465923093700/tm2324200-1_4seq1.xml","form_type":"4"}},{"id":1833205,"issuer":{"id":8350,"kind":"organization","name":"MUSTANG BIO, INC."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK, PAR VALUE $0.0001","published_at":"2023-07-07T20:06:53.000Z","date":"2023-07-05","kind":"grant","planned":false,"acquired":true,"shares":7246,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted 7,246 restricted shares pursuant to the Issuer's 2016 Incentive Plan on July 5, 2023. The shares will vest on July 5, 2026, subject to the Reporting Person's continued service on the Issuer's board on such date."},{"field":"shares","element":"transactionShares","label":"F2","text":"Effective April 3, 2023, the Issuer effected a fifteen-for-one reverse stock split of its common stock (the \"Reverse Stock Split\"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Stock Split."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Effective April 3, 2023, the Issuer effected a fifteen-for-one reverse stock split of its common stock (the \"Reverse Stock Split\"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Stock Split."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes restricted share units, which vest over various time periods."}],"balance_after":60525,"source":{"system":"sec-edgar","filing":"0001104659-23-079114","document":"tm2320790-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465923079114/tm2320790-4_4seq1.xml","form_type":"4"}},{"id":1837777,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee stock option (right to buy)","published_at":"2023-07-05T20:08:48.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in accordance with the following schedule: (i) one-third of the shares subject to the option vest on January 1, 2024; (ii) one-third of the shares subject to the option vest on January 1, 2025; and (iii) one-third of the shares subject to the option vest on January 1, 2026."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Effective September 22, 2022, the Issuer effected a one-for-fifteen reverse stock split of its common stock (the \"Reverse Stock Split\"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Stock Split."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Effective September 22, 2022, the Issuer effected a one-for-fifteen reverse stock split of its common stock (the \"Reverse Stock Split\"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Stock Split."}],"balance_after":100000,"derivative":{"exercise_price":1.14,"expiration_date":"2033-06-30","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001104659-23-078096","document":"tm2320488d4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465923078096/tm2320488d4_4seq1.xml","form_type":"4"}},{"id":1854963,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2023-06-16T00:00:57.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":17483,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 17,483 shares of restricted Common Stock will vest on June 13, 2026, subject to Dr. Rosenwald's continued service on the board on such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted shares of Common Stock which vest over various time periods, subject to Dr. Rosenwald's continued service on the board."}],"balance_after":50123,"source":{"system":"sec-edgar","filing":"0001104659-23-071759","document":"tm2318836-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465923071759/tm2318836-4_4seq1.xml","form_type":"4"}},{"id":1933067,"issuer":{"id":8350,"kind":"organization","name":"MUSTANG BIO, INC."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK, PAR VALUE $0.0001","published_at":"2023-04-03T20:50:59.000Z","date":"2022-09-13","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":0.5164,"value":2582.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired as purchases made under the Issuer's Employee Stock Purchase Plan (\"ESPP\") during the ESPP offering period."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted share units, which vest over various time periods."}],"balance_after":299181,"source":{"system":"sec-edgar","filing":"0001104659-23-040932","document":"tm2311237-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465923040932/tm2311237-5_4seq1.xml","form_type":"4"}},{"id":1933066,"issuer":{"id":8350,"kind":"organization","name":"MUSTANG BIO, INC."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK, PAR VALUE $0.0001","published_at":"2023-04-03T20:50:59.000Z","date":"2022-07-29","kind":"grant","planned":false,"acquired":true,"shares":71664,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The Reporting Person was granted 71,664 restricted shares pursuant to the Issuer's 2016 Incentive Plan on July 29, 2022. The shares will vest on June 17, 2025, subject to the Reporting Person's continued service on the Issuer's board on such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted share units, which vest over various time periods."}],"balance_after":294181,"source":{"system":"sec-edgar","filing":"0001104659-23-040932","document":"tm2311237-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465923040932/tm2311237-5_4seq1.xml","form_type":"4"}},{"id":1933065,"issuer":{"id":8350,"kind":"organization","name":"MUSTANG BIO, INC."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK, PAR VALUE $0.0001","published_at":"2023-04-03T20:50:59.000Z","date":"2022-03-18","kind":"purchase","planned":false,"acquired":true,"shares":4094,"price":0.739,"value":3025.466,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired as purchases made under the Issuer's Employee Stock Purchase Plan (\"ESPP\") during the ESPP offering period."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted share units, which vest over various time periods."}],"balance_after":222517,"source":{"system":"sec-edgar","filing":"0001104659-23-040932","document":"tm2311237-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465923040932/tm2311237-5_4seq1.xml","form_type":"4"}},{"id":2017624,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President, CEO & Chairman"}}],"security":"COMMON STOCK, PAR VALUE $0.001","published_at":"2023-02-14T21:10:16.000Z","date":"2023-02-10","kind":"purchase","acquired":true,"shares":2395209,"price":0.835,"value":1999999.515,"ownership":{"direct":true},"balance_after":15349091,"source":{"system":"sec-edgar","filing":"0001104659-23-021617","document":"tm236803-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465923021617/tm236803-4_4seq1.xml","form_type":"4"}},{"id":2070002,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President, CEO & Chairman"}}],"security":"COMMON STOCK, PAR VALUE $0.001","published_at":"2023-01-05T02:28:22.000Z","date":"2023-01-01","kind":"grant","acquired":true,"shares":1219294,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The Reporting Person was granted 1,219,294 restricted shares pursuant to the Issuer's Long-Term Incentive Plan on January 1, 2023."}],"balance_after":12953882,"source":{"system":"sec-edgar","filing":"0001104659-23-001103","document":"tm231728-9_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465923001103/tm231728-9_4seq1.xml","form_type":"4"}},{"id":2070001,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President, CEO & Chairman"}}],"security":"COMMON STOCK, PAR VALUE $0.001","published_at":"2023-01-05T02:28:22.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":4264,"price":0.73,"value":3112.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c)."}],"balance_after":11734588,"source":{"system":"sec-edgar","filing":"0001104659-23-001103","document":"tm231728-9_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465923001103/tm231728-9_4seq1.xml","form_type":"4"}},{"id":2097014,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT, CEO & CHAIRMAN"}}],"security":"COMMON STOCK, PAR VALUE $0.001","published_at":"2022-12-05T12:31:38.000Z","date":"2022-12-01","kind":"purchase","acquired":true,"shares":100000,"price":0.6796,"value":67960.0,"ownership":{"direct":true},"balance_after":11730324,"source":{"system":"sec-edgar","filing":"0001104659-22-124392","document":"tm2231935-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465922124392/tm2231935-1_4seq1.xml","form_type":"4"}},{"id":2099012,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT, CEO & CHAIRMAN"}}],"security":"COMMON STOCK, PAR VALUE $0.001","published_at":"2022-12-02T21:18:04.000Z","date":"2022-11-30","kind":"purchase","acquired":true,"shares":5000,"price":0.56,"value":2800.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired as purchases made under the Issuer's Employee Stock Purchase Plan (\"ESPP\") during the ESPP offering period. Under the ESPP, 5,000 shares is the maximum amount an individual employee may purchase during an offering period."}],"balance_after":11630324,"source":{"system":"sec-edgar","filing":"0001104659-22-124108","document":"tm2231877-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465922124108/tm2231877-2_4seq1.xml","form_type":"4"}},{"id":2133176,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT, CEO & CHAIRMAN"}}],"security":"COMMON STOCK, PAR VALUE $0.001","published_at":"2022-10-24T12:00:59.000Z","date":"2022-10-21","kind":"purchase","acquired":true,"shares":100000,"price":0.695,"value":69500.0,"ownership":{"direct":true},"balance_after":11625324,"source":{"system":"sec-edgar","filing":"0001104659-22-110780","document":"tm2228777-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465922110780/tm2228777-1_4seq1.xml","form_type":"4"}},{"id":2202933,"issuer":{"id":6273,"kind":"organization","name":"Journey Medical Corp"},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0001 per share","published_at":"2022-07-25T13:40:22.000Z","date":"2022-07-21","kind":"grant","acquired":true,"shares":14245,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On July 21, 2022, the reporting person was granted 14,245 restricted stock units pursuant to the Issuer's 2015 Stock Plan, which will vest in full on July 21, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 14,245 restricted stock units, which will vest as set forth in footnote 1."}],"balance_after":14245,"source":{"system":"sec-edgar","filing":"0001104659-22-082291","document":"tm2221508-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465922082291/tm2221508-7_4seq1.xml","form_type":"4"}},{"id":2222350,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2022-06-25T01:54:17.000Z","date":"2022-06-16","kind":"grant","acquired":true,"shares":47619,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 47,619 shares of restricted Common Stock will vest on June 16, 2025, subject to Dr. Rosenwald's continued service on the board on such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted shares of Common Stock which vest over various time periods, subject to Dr. Rosenwald's continued service on the board."}],"balance_after":326401,"source":{"system":"sec-edgar","filing":"0001104659-22-074466","document":"tm2219319-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465922074466/tm2219319-3_4seq1.xml","form_type":"4"}},{"id":2288217,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT, CEO & CHAIRMAN"}}],"security":"COMMON STOCK, PAR VALUE $0.001","published_at":"2022-04-29T20:22:00.000Z","date":"2022-01-01","kind":"grant","acquired":true,"shares":1102986,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"The reporting person was granted 1,102,986 restricted shares pursuant to the issuer's Long-Term Incentive Plan on January 1, 2022."}],"balance_after":11525324,"source":{"system":"sec-edgar","filing":"0001104659-22-053615","document":"tm2213913-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465922053615/tm2213913-6_4seq1.xml","form_type":"4"}},{"id":2288216,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT, CEO & CHAIRMAN"}}],"security":"COMMON STOCK, PAR VALUE $0.001","published_at":"2022-04-29T20:22:00.000Z","date":"2021-12-01","kind":"grant","acquired":true,"shares":1250,"price":2.42,"value":3025.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares acquired as purchases made under the Issuer's Employee Stock Purchase Plan (\"ESPP\") during the ESPP offering period."}],"balance_after":10422338,"source":{"system":"sec-edgar","filing":"0001104659-22-053615","document":"tm2213913-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465922053615/tm2213913-6_4seq1.xml","form_type":"4"}},{"id":2288215,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT, CEO & CHAIRMAN"}}],"security":"COMMON STOCK, PAR VALUE $0.001","published_at":"2022-04-29T20:22:00.000Z","date":"2021-11-16","kind":"other","acquired":true,"shares":4619,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The shares were issued upon the consummation of Journey Medical Corporation (\"Journey's\")  initial public offering as a partial dividend pursuant to the Dividend Payment and Exchange Agreement executed by Fortress Biotech, Inc. on March 31, 2021 in favor of the holders of Journey's 8% Cumulative Convertible Class A Preferred Stock."}],"balance_after":10421088,"source":{"system":"sec-edgar","filing":"0001104659-22-053615","document":"tm2213913-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465922053615/tm2213913-6_4seq1.xml","form_type":"4"}},{"id":2288214,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT, CEO & CHAIRMAN"}}],"security":"COMMON STOCK, PAR VALUE $0.001","published_at":"2022-04-29T20:22:00.000Z","date":"2021-09-30","kind":"other","acquired":true,"shares":8133,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares were issued as a dividend pursuant to the Dividend Payment and Exchange Agreement executed by Fortress Biotech, Inc. on March 31, 2021 in favor of the holders of Journey Medical Corporation's 8% Cumulative Convertible Class A Preferred Stock."}],"balance_after":10416469,"source":{"system":"sec-edgar","filing":"0001104659-22-053615","document":"tm2213913-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465922053615/tm2213913-6_4seq1.xml","form_type":"4"}},{"id":2288213,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT, CEO & CHAIRMAN"}}],"security":"COMMON STOCK, PAR VALUE $0.001","published_at":"2022-04-29T20:22:00.000Z","date":"2021-06-01","kind":"grant","acquired":true,"shares":1297,"price":2.31,"value":2996.07,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares acquired as purchases made under the Issuer's Employee Stock Purchase Plan (\"ESPP\") during the ESPP offering period."}],"balance_after":10408336,"source":{"system":"sec-edgar","filing":"0001104659-22-053615","document":"tm2213913-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465922053615/tm2213913-6_4seq1.xml","form_type":"4"}},{"id":2560266,"issuer":{"id":8350,"kind":"organization","name":"MUSTANG BIO, INC."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2021-09-24T21:25:44.000Z","date":"2021-08-31","kind":"grant","acquired":true,"shares":1170,"price":2.58,"value":3018.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired under the Mustang Bio, Inc. Employee Share Purchase Plan (\"ESPP\") for the ESPP purchase period beginning on March 1, 2021 and ending on August 31, 2021 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the fair market value closing price of the Issuer's ordinary shares on August 31, 2021 (the purchase date of the offering period)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted shares, which vest over various time periods."}],"balance_after":218423,"source":{"system":"sec-edgar","filing":"0001104659-21-119389","document":"tm2128458-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465921119389/tm2128458-2_4seq1.xml","form_type":"4"}},{"id":2638743,"issuer":{"id":8350,"kind":"organization","name":"MUSTANG BIO, INC."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2021-07-08T20:32:20.000Z","date":"2021-06-28","kind":"grant","acquired":true,"shares":13774,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted 13,774 restricted shares pursuant to the Issuer's 2016 Incentive Plan on June 28, 2021. The shares will vest on June 17, 2024, subject to the Reporting Person's continued service on the Issuer's board on such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted share units, which vest over various time periods."}],"balance_after":217253,"source":{"system":"sec-edgar","filing":"0001104659-21-090243","document":"tm2121675-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465921090243/tm2121675-4_4seq1.xml","form_type":"4"}},{"id":2672759,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2021-06-12T00:00:15.000Z","date":"2021-06-10","kind":"grant","acquired":true,"shares":16502,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 16,502 shares of restricted Common Stock will vest on June 10, 2024, subject to Dr. Rosenwald's continued service on the board on such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted shares of Common Stock which vest over various time periods, subject to Dr. Rosenwald's continued service on the board."}],"balance_after":278782,"source":{"system":"sec-edgar","filing":"0001104659-21-080362","document":"tm2119513-3_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465921080362/tm2119513-3_4.xml","form_type":"4"}},{"id":2752375,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT, CEO & CHAIRMAN"}}],"security":"COMMON STOCK, PAR VALUE $0.001","published_at":"2021-04-09T21:24:52.000Z","date":"2021-01-01","kind":"grant","acquired":true,"shares":1030339,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The Reporting Person was granted 1,030,339 restricted shares pursuant to the Issuer's Long Term Incentive Plan on January 1, 2021."}],"balance_after":10407039,"source":{"system":"sec-edgar","filing":"0001104659-21-048830","document":"tm219139d6_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465921048830/tm219139d6_4.xml","form_type":"4"}},{"id":2752374,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT, CEO & CHAIRMAN"}}],"security":"COMMON STOCK, PAR VALUE $0.001","published_at":"2021-04-09T21:24:52.000Z","date":"2020-12-01","kind":"grant","acquired":true,"shares":1250,"price":2.34,"value":2925.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired as purchases made under the Issuer's Employee Stock Purchase Plan (\"ESPP\") during the ESPP offering period."}],"balance_after":9376700,"source":{"system":"sec-edgar","filing":"0001104659-21-048830","document":"tm219139d6_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465921048830/tm219139d6_4.xml","form_type":"4"}},{"id":2752373,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT, CEO & CHAIRMAN"}}],"security":"COMMON STOCK, PAR VALUE $0.001","published_at":"2021-04-09T21:24:52.000Z","date":"2020-06-01","kind":"grant","acquired":true,"shares":1602,"price":1.69,"value":2707.38,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired as purchases made under the Issuer's Employee Stock Purchase Plan (\"ESPP\") during the ESPP offering period."}],"balance_after":9375450,"source":{"system":"sec-edgar","filing":"0001104659-21-048830","document":"tm219139d6_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465921048830/tm219139d6_4.xml","form_type":"4"}},{"id":2790033,"issuer":{"id":8350,"kind":"organization","name":"MUSTANG BIO, INC."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2021-03-15T10:31:22.000Z","date":"2021-02-26","kind":"grant","acquired":true,"shares":1043,"price":2.83,"value":2951.69,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired under the Mustang Bio, Inc. Employee Share Purchase Plan (\"ESPP\") for the ESPP purchase period beginning on September 1, 2020 and ending on February 28, 2021 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the fair market value closing price of the Issuer's ordinary shares on September 1, 2020 (the purchase date of the offering period)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted share units, which vest over various time periods."}],"balance_after":203479,"source":{"system":"sec-edgar","filing":"0001104659-21-035854","document":"tm219639d2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465921035854/tm219639d2_4seq1.xml","form_type":"4"}},{"id":2935256,"issuer":{"id":8350,"kind":"organization","name":"MUSTANG BIO, INC."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2020-12-22T21:21:29.000Z","date":"2020-12-14","kind":"purchase","acquired":true,"shares":100000,"price":2.66,"value":266000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the sale transactions on December 14, 2020, was $2.59 to $2.73. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a shareholder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted share units, which vest over various time periods."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"1,183 ESPP shares were inadvertently omitted from Dr. Rosenwald's original Form 4 filed on December 15, 2020."}],"balance_after":202436,"source":{"system":"sec-edgar","filing":"0001104659-20-138584","document":"tm2039180-3_4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465920138584/tm2039180-3_4a.xml","form_type":"4/A","original_submission_date":"2020-12-15"}},{"id":2935255,"issuer":{"id":8350,"kind":"organization","name":"MUSTANG BIO, INC."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2020-12-22T21:21:29.000Z","date":"2020-08-31","kind":"grant","acquired":true,"shares":1182,"price":2.48,"value":2931.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired under the Mustang Bio, Inc. Employee Share Purchase Plan (\"ESPP\") for the ESPP purchase period beginning on March 1, 2020 and ending on August 31, 2020 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the fair market value closing price of the Issuer's ordinary shares on February 28, 2020 (the purchase date of the offering period)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted share units, which vest over various time periods."}],"balance_after":102436,"source":{"system":"sec-edgar","filing":"0001104659-20-138584","document":"tm2039180-3_4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465920138584/tm2039180-3_4a.xml","form_type":"4/A","original_submission_date":"2020-12-15"}},{"id":2935254,"issuer":{"id":8350,"kind":"organization","name":"MUSTANG BIO, INC."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2020-12-22T21:20:46.000Z","date":"2020-07-14","kind":"grant","acquired":true,"shares":16611,"price":2.48,"value":41195.28,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted share units, which vest over various time periods."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"831 ESPP shares were inadvertently omitted from Dr. Rosenwald's original Form 4 filed on August 19, 2020."}],"balance_after":101254,"source":{"system":"sec-edgar","filing":"0001104659-20-138582","document":"tm2039180-2_4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465920138582/tm2039180-2_4a.xml","form_type":"4/A","original_submission_date":"2020-08-19"}},{"id":2935253,"issuer":{"id":8350,"kind":"organization","name":"MUSTANG BIO, INC."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2020-12-22T21:20:46.000Z","date":"2020-02-28","kind":"grant","acquired":true,"shares":831,"price":2.48,"value":2060.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired under the Mustang Bio, Inc. Employee Share Purchase Plan (\"ESPP\") for the ESPP purchase period beginning on September 1, 2019 and ending on February 29, 2020 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the fair market value closing price of the Issuer's ordinary shares on February 28, 2020 (the last trading day of the offering period)"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted share units, which vest over various time periods."}],"balance_after":84643,"source":{"system":"sec-edgar","filing":"0001104659-20-138582","document":"tm2039180-2_4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465920138582/tm2039180-2_4a.xml","form_type":"4/A","original_submission_date":"2020-08-19"}},{"id":2945290,"issuer":{"id":8350,"kind":"organization","name":"MUSTANG BIO, INC."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2020-12-15T13:15:36.000Z","date":"2020-12-14","kind":"purchase","acquired":true,"shares":100000,"price":2.66,"value":266000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average purchase price of multiple same-way open market purchase transactions effected by the Reporting Person on the same day at different prices through a purchase order executed by a broker-dealer. The Reporting Person reported on a single line all such transactions that occurred within a one-dollar price range. The range of prices for the purchase transactions on December 14, 2020, was $2.59 to $2.73. The Reporting Person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the Issuer, or a shareholder of the Issuer, full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted share units, which vest over various time periods."}],"balance_after":200423,"source":{"system":"sec-edgar","filing":"0001104659-20-135513","document":"tm2038479d1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465920135513/tm2038479d1_4.xml","form_type":"4"}},{"id":3043057,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT, CEO & CHAIRMAN"}}],"security":"SERIES A CUMULATIVE PERPETUAL PREFERRED STOCK","published_at":"2020-09-01T12:32:10.000Z","date":"2020-08-26","kind":"purchase","acquired":true,"shares":52500,"price":18,"value":945000.0,"ownership":{"direct":true},"balance_after":92500,"source":{"system":"sec-edgar","filing":"0001104659-20-101100","document":"tm2029961-1_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465920101100/tm2029961-1_4.xml","form_type":"4"}},{"id":3052927,"issuer":{"id":8350,"kind":"organization","name":"MUSTANG BIO, INC."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-19T20:32:53.000Z","date":"2020-07-14","kind":"grant","acquired":true,"shares":16611,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 100,423 restricted stock units which vest over time."}],"balance_after":100423,"source":{"system":"sec-edgar","filing":"0001104659-20-096925","document":"tm2028955d3_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465920096925/tm2028955d3_4.xml","form_type":"4"}},{"id":3117474,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2020-06-09T20:33:44.000Z","date":"2020-06-05","kind":"grant","acquired":true,"shares":24390,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 24,390 shares of restricted Common Stock will vest on June 5, 2023, subject to Dr. Rosenwald's continued service on the board on such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted shares of Common Stock which vest over various time periods, subject to Dr. Rosenwald's continued service on the board."}],"balance_after":262280,"source":{"system":"sec-edgar","filing":"0001104659-20-071416","document":"tm2022118d6_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465920071416/tm2022118d6_4.xml","form_type":"4"}},{"id":3211817,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT, CEO & CHAIRMAN"}}],"security":"COMMON STOCK, PAR VALUE $0.001","published_at":"2020-03-13T20:08:06.000Z","date":"2020-01-01","kind":"grant","acquired":true,"shares":801536,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The Reporting Person was granted 801,536 restricted shares pursuant to the Issuer's Long Term Incentive Plan on January 1, 2020."}],"balance_after":9373848,"source":{"system":"sec-edgar","filing":"0001104659-20-033116","document":"tm2011481-6_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465920033116/tm2011481-6_form4.xml","form_type":"4"}},{"id":3211816,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT, CEO & CHAIRMAN"}}],"security":"COMMON STOCK, PAR VALUE $0.001","published_at":"2020-03-13T20:08:06.000Z","date":"2019-12-01","kind":"purchase","acquired":true,"shares":1123,"price":2.06,"value":2313.38,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired as purchases made under the Issuer's Employee Stock Purchase Plan (\"ESPP\") during the ESPP offering period."}],"balance_after":8572312,"source":{"system":"sec-edgar","filing":"0001104659-20-033116","document":"tm2011481-6_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465920033116/tm2011481-6_form4.xml","form_type":"4"}},{"id":3211815,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT, CEO & CHAIRMAN"}}],"security":"COMMON STOCK, PAR VALUE $0.001","published_at":"2020-03-13T20:08:06.000Z","date":"2019-06-03","kind":"purchase","acquired":true,"shares":1467,"price":1.1,"value":1613.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired as purchases made under the Issuer's Employee Stock Purchase Plan (\"ESPP\") during the ESPP offering period."}],"balance_after":8571189,"source":{"system":"sec-edgar","filing":"0001104659-20-033116","document":"tm2011481-6_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465920033116/tm2011481-6_form4.xml","form_type":"4"}},{"id":3308677,"issuer":{"id":8350,"kind":"organization","name":"MUSTANG BIO, INC."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-17T22:42:51.000Z","date":"2019-08-28","kind":"grant","acquired":true,"shares":13812,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 33,812 restricted stock units which vest over time."}],"balance_after":83812,"source":{"system":"sec-edgar","filing":"0001104659-20-005208","document":"tm203350d1_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465920005208/tm203350d1_form4.xml","form_type":"4"}},{"id":3308676,"issuer":{"id":8350,"kind":"organization","name":"MUSTANG BIO, INC."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-17T22:41:20.000Z","date":"2018-06-14","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"10,000 restricted stock units were inadvertently omitted from Dr. Rosenwald's original Form 4 filed on 11/05/2018."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 20,000 restricted stock units which vest over time."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001104659-20-005207","document":"tm203350d6_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465920005207/tm203350d6_form4.xml","form_type":"4/A","original_submission_date":"2018-11-05"}},{"id":3361753,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2019-11-22T13:00:34.000Z","date":"2019-11-20","kind":"purchase","acquired":true,"shares":100000,"price":1.27,"value":127000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes restricted shares of Common Stock which vest over various time periods, subject to Dr. Rosenwald's continued service on the board."}],"balance_after":237890,"source":{"system":"sec-edgar","filing":"0001104659-19-066411","document":"tm19236741_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000110465919066411/tm19236741_form4.xml","form_type":"4"}},{"id":3458771,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT, CEO & CHAIRMAN"}}],"security":"COMMON STOCK, PAR VALUE $0.001","published_at":"2019-07-19T11:00:36.000Z","date":"2019-07-18","kind":"grant","acquired":true,"shares":396825,"price":1.26,"value":499999.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares acquired as a result of prepayment of debt owed to Dr. Rosenwald that was held in the name of Opus Point Healthcare Innovations Fund, LP (\"Opus\"), an investment fund co-owned by Dr. Rosenwald, in the form of the Company's common stock (measured at the closing price on July 18, 2019), under that certain Amended & Restated Credit Facility Agreement, dated as of March 12, 2018, by and between the Company and Opus."},{"field":"shares","element":"transactionShares","label":"F1","text":"Shares acquired as a result of prepayment of debt owed to Dr. Rosenwald that was held in the name of Opus Point Healthcare Innovations Fund, LP (\"Opus\"), an investment fund co-owned by Dr. Rosenwald, in the form of the Company's common stock (measured at the closing price on July 18, 2019), under that certain Amended & Restated Credit Facility Agreement, dated as of March 12, 2018, by and between the Company and Opus."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares acquired as a result of prepayment of debt owed to Dr. Rosenwald that was held in the name of Opus Point Healthcare Innovations Fund, LP (\"Opus\"), an investment fund co-owned by Dr. Rosenwald, in the form of the Company's common stock (measured at the closing price on July 18, 2019), under that certain Amended & Restated Credit Facility Agreement, dated as of March 12, 2018, by and between the Company and Opus."}],"balance_after":8569722,"source":{"system":"sec-edgar","filing":"0001144204-19-035107","document":"tv525484_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000114420419035107/tv525484_4.xml","form_type":"4"}},{"id":3490440,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2019-06-14T20:48:09.000Z","date":"2019-06-13","kind":"grant","acquired":true,"shares":11442,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 11,442 shares of restricted Common Stock will vest on June 13, 2022, subject to Dr. Rosenwald's continued service on the board on such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted shares of Common Stock which vest over various time periods, subject to Dr. Rosenwald's continued service on the board."}],"balance_after":137890,"source":{"system":"sec-edgar","filing":"0001144204-19-031021","document":"tv523632_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000114420419031021/tv523632_4.xml","form_type":"4"}},{"id":3557004,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2019-04-12T20:10:22.000Z","date":"2019-01-01","kind":"grant","acquired":true,"shares":648204,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted 586,428, 164,473 and 648,204 restricted shares pursuant to the Company's Long Term Incentive Plan on January 1, 2018, July 3, 2018 and January 1, 2019, respectively."}],"balance_after":8172897,"source":{"system":"sec-edgar","filing":"0001144204-19-019499","document":"tv516220_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/941841/000114420419019499/tv516220_4.xml","form_type":"4"}},{"id":3557003,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2019-04-12T20:10:22.000Z","date":"2018-12-01","kind":"grant","acquired":true,"shares":1514,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Shares were acquired pursuant to the Company's Employee Stock Purchase Plan."}],"balance_after":7524693,"source":{"system":"sec-edgar","filing":"0001144204-19-019499","document":"tv516220_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/941841/000114420419019499/tv516220_4.xml","form_type":"4"}},{"id":3557002,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2019-04-12T20:10:22.000Z","date":"2018-07-03","kind":"grant","acquired":true,"shares":164473,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted 586,428, 164,473 and 648,204 restricted shares pursuant to the Company's Long Term Incentive Plan on January 1, 2018, July 3, 2018 and January 1, 2019, respectively."}],"balance_after":7523179,"source":{"system":"sec-edgar","filing":"0001144204-19-019499","document":"tv516220_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/941841/000114420419019499/tv516220_4.xml","form_type":"4"}},{"id":3557001,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Common Stock","published_at":"2019-04-12T20:10:22.000Z","date":"2018-01-01","kind":"grant","acquired":true,"shares":586428,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was granted 586,428, 164,473 and 648,204 restricted shares pursuant to the Company's Long Term Incentive Plan on January 1, 2018, July 3, 2018 and January 1, 2019, respectively."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,346 shares acquired pursuant to the Company's Employee Stock Purchase Plan."}],"balance_after":7358706,"source":{"system":"sec-edgar","filing":"0001144204-19-019499","document":"tv516220_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000114420419019499/tv516220_4.xml","form_type":"4"}},{"id":3768452,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2018-11-13T17:23:34.000Z","date":"2018-11-09","kind":"purchase","acquired":true,"shares":49666,"price":2.35,"value":116715.1,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The range of prices for the sale transactions on November 7, 2018, was $2.05 to $2.26, the range of prices for the sale transactions on November 8, 2018, was $2.19 to $2.34, and the range of prices for the sale transactions on November 9, 2018, was $2.30 to $2.44. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units which vest over various time periods, subject to Dr. Rosenwald's continued service on the board on such date."}],"balance_after":126448,"source":{"system":"sec-edgar","filing":"0001144204-18-059191","document":"tv507113_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/941841/000114420418059191/tv507113_4.xml","form_type":"4"}},{"id":3768451,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2018-11-13T17:23:34.000Z","date":"2018-11-08","kind":"purchase","acquired":true,"shares":48234,"price":2.24,"value":108044.16,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The range of prices for the sale transactions on November 7, 2018, was $2.05 to $2.26, the range of prices for the sale transactions on November 8, 2018, was $2.19 to $2.34, and the range of prices for the sale transactions on November 9, 2018, was $2.30 to $2.44. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units which vest over various time periods, subject to Dr. Rosenwald's continued service on the board on such date."}],"balance_after":76782,"source":{"system":"sec-edgar","filing":"0001144204-18-059191","document":"tv507113_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/941841/000114420418059191/tv507113_4.xml","form_type":"4"}},{"id":3768450,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2018-11-13T17:23:34.000Z","date":"2018-11-07","kind":"purchase","acquired":true,"shares":2100,"price":2.12,"value":4452.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average sale price of multiple same-way open market sale transactions effected by the Reporting Person on the same day at different prices through a sale order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The range of prices for the sale transactions on November 7, 2018, was $2.05 to $2.26, the range of prices for the sale transactions on November 8, 2018, was $2.19 to $2.34, and the range of prices for the sale transactions on November 9, 2018, was $2.30 to $2.44. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes restricted stock units which vest over various time periods, subject to Dr. Rosenwald's continued service on the board on such date."}],"balance_after":28548,"source":{"system":"sec-edgar","filing":"0001144204-18-059191","document":"tv507113_4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000114420418059191/tv507113_4.xml","form_type":"4"}},{"id":3774797,"issuer":{"id":8350,"kind":"organization","name":"MUSTANG BIO, INC."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2018-11-06T01:06:21.000Z","date":"2018-11-02","kind":"purchase","acquired":true,"shares":50000,"price":4.41,"value":220500.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 20,000 restricted stock units which vest over time."}],"balance_after":70000,"source":{"system":"sec-edgar","filing":"0001144204-18-057391","document":"tv506421_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000114420418057391/tv506421_form4.xml","form_type":"4"}},{"id":3850056,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-09T01:46:58.000Z","date":"2018-08-07","kind":"gift","acquired":true,"shares":14663,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 14,663 shares of restricted common stock will vest on August 7, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 24,663 shares of restricted stock."}],"balance_after":84663,"source":{"system":"sec-edgar","filing":"0001144204-18-042960","document":"tv500469_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000114420418042960/tv500469_form4.xml","form_type":"4"}},{"id":3892948,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2018-06-15T21:23:44.000Z","date":"2018-06-14","kind":"grant","acquired":true,"shares":16448,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 16,448 shares of restricted Common Stock will vest on June 14, 2021, subject to Dr. Rosenwald's continued service on the board on such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents shares of restricted Common Stock which vest over various time periods."}],"balance_after":26448,"source":{"system":"sec-edgar","filing":"0001144204-18-034455","document":"tv496607_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000114420418034455/tv496607_form4.xml","form_type":"4"}},{"id":3897486,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-12T21:31:15.000Z","date":"2018-06-08","kind":"purchase","acquired":true,"shares":5234,"price":4.3421,"value":22726.5514,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 10,000 shares of restricted stock."}],"balance_after":70000,"source":{"system":"sec-edgar","filing":"0001144204-18-033938","document":"tv496382_form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/941841/000114420418033938/tv496382_form4a.xml","form_type":"4/A","original_submission_date":"2018-06-11"}},{"id":3897485,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-12T21:31:15.000Z","date":"2018-06-07","kind":"purchase","acquired":true,"shares":14800,"price":4.3222,"value":63968.56,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 10,000 shares of restricted stock."}],"balance_after":64766,"source":{"system":"sec-edgar","filing":"0001144204-18-033938","document":"tv496382_form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/941841/000114420418033938/tv496382_form4a.xml","form_type":"4/A","original_submission_date":"2018-06-11"}},{"id":3897484,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-12T21:31:15.000Z","date":"2018-06-06","kind":"purchase","acquired":true,"shares":9100,"price":4.349,"value":39575.9,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 10,000 shares of restricted stock."}],"balance_after":49966,"source":{"system":"sec-edgar","filing":"0001144204-18-033938","document":"tv496382_form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/941841/000114420418033938/tv496382_form4a.xml","form_type":"4/A","original_submission_date":"2018-06-11"}},{"id":3897483,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-12T21:31:15.000Z","date":"2018-06-05","kind":"purchase","acquired":true,"shares":8400,"price":4.2796,"value":35948.64,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 10,000 shares of restricted stock."}],"balance_after":40866,"source":{"system":"sec-edgar","filing":"0001144204-18-033938","document":"tv496382_form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/941841/000114420418033938/tv496382_form4a.xml","form_type":"4/A","original_submission_date":"2018-06-11"}},{"id":3897482,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-12T21:31:15.000Z","date":"2018-06-04","kind":"purchase","acquired":true,"shares":3800,"price":4.1897,"value":15920.86,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 10,000 shares of restricted stock."}],"balance_after":32466,"source":{"system":"sec-edgar","filing":"0001144204-18-033938","document":"tv496382_form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/941841/000114420418033938/tv496382_form4a.xml","form_type":"4/A","original_submission_date":"2018-06-11"}},{"id":3897481,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-12T21:31:15.000Z","date":"2018-06-01","kind":"purchase","acquired":true,"shares":8666,"price":4.1545,"value":36002.897,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 10,000 shares of restricted stock."}],"balance_after":28666,"source":{"system":"sec-edgar","filing":"0001144204-18-033938","document":"tv496382_form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000114420418033938/tv496382_form4a.xml","form_type":"4/A","original_submission_date":"2018-06-11"}},{"id":3899081,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-11T21:37:56.000Z","date":"2018-06-08","kind":"purchase","acquired":true,"shares":5234,"price":4.34,"value":22715.56,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Weighted average price. These shares were purchased in multiple transactions ranging from $4.20 to $4.40. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 10,000 shares of restricted stock."}],"balance_after":25234,"source":{"system":"sec-edgar","filing":"0001144204-18-033791","document":"tv496320_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000114420418033791/tv496320_form4.xml","form_type":"4"}},{"id":4169440,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT, CEO"}}],"security":"SERIES A CUMULATIVE REDEEMABLE PERPETUAL PREFERRED STOCK","published_at":"2017-11-08T23:02:09.000Z","date":"2017-11-06","kind":"purchase","acquired":true,"shares":40000,"price":25,"value":1000000.0,"ownership":{"direct":true},"balance_after":40000,"source":{"system":"sec-edgar","filing":"0001144204-17-057351","document":"tv478998_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000114420417057351/tv478998_form4.xml","form_type":"4"}},{"id":4189467,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-10-10T12:36:10.000Z","date":"2017-10-09","kind":"purchase","acquired":true,"shares":1350,"price":5.4,"value":7290.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 10,000 shares of restricted stock."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001144204-17-051784","document":"tv476670_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/941841/000114420417051784/tv476670_form4.xml","form_type":"4"}},{"id":4189466,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-10-10T12:36:10.000Z","date":"2017-10-06","kind":"purchase","acquired":true,"shares":2900,"price":5.63,"value":16327.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 10,000 shares of restricted stock."}],"balance_after":18650,"source":{"system":"sec-edgar","filing":"0001144204-17-051784","document":"tv476670_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/941841/000114420417051784/tv476670_form4.xml","form_type":"4"}},{"id":4189465,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-10-10T12:36:10.000Z","date":"2017-10-05","kind":"purchase","acquired":true,"shares":3550,"price":5.6,"value":19880.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 10,000 shares of restricted stock."}],"balance_after":15750,"source":{"system":"sec-edgar","filing":"0001144204-17-051784","document":"tv476670_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/941841/000114420417051784/tv476670_form4.xml","form_type":"4"}},{"id":4189464,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-10-10T12:36:10.000Z","date":"2017-10-04","kind":"purchase","acquired":true,"shares":2200,"price":5.6,"value":12320.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 10,000 shares of restricted stock."}],"balance_after":12200,"source":{"system":"sec-edgar","filing":"0001144204-17-051784","document":"tv476670_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000114420417051784/tv476670_form4.xml","form_type":"4"}},{"id":4258633,"issuer":{"id":78931,"kind":"organization","name":"Checkpoint Therapeutics, Inc.","symbol":"CKPT"},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"COMMON STOCK","published_at":"2017-07-12T21:00:28.000Z","date":"2017-07-10","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The 10,000 shares of restricted Common Stock will vest on July 10, 2020, subject to Dr. Rosenwald's continued service on the board on such date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The 10,000 shares of restricted Common Stock will vest on July 10, 2020, subject to Dr. Rosenwald's continued service on the board on such date."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001144204-17-036573","document":"v470709_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000114420417036573/v470709_form4.xml","form_type":"4"}},{"id":4479595,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock, par value $0.001","published_at":"2017-01-27T21:12:52.000Z","date":"2017-01-01","kind":"grant","acquired":true,"shares":552698,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents an award of restricted shares of the Issuer's common stock made pursuant to the Fortress Biotech, Inc. Long Term Incentive Plan."}],"balance_after":5857168,"source":{"system":"sec-edgar","filing":"0001638599-17-000116","document":"doc4_4441.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/941841/000163859917000116/doc4_4441.xml","form_type":"4"}},{"id":4479594,"issuer":{"id":6822,"kind":"organization","name":"Fortress Biotech, Inc."},"owners":[{"id":35267,"kind":"person","name":"ROSENWALD LINDSAY A MD","position":1,"cik":"0000941841","reported_name":"ROSENWALD LINDSAY A MD","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock, par value $0.001","published_at":"2017-01-27T21:12:52.000Z","date":"2016-12-01","kind":"purchase","acquired":true,"shares":731,"price":2.03,"value":1483.93,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired under the Issuer's 2012 Employee Stock Purchase Plan."}],"balance_after":5304470,"source":{"system":"sec-edgar","filing":"0001638599-17-000116","document":"doc4_4441.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/941841/000163859917000116/doc4_4441.xml","form_type":"4"}}]}